Feature | TCT | September 06, 2023

CRF Announces TCT 2023 Late-breaking Clinical Trials

Annual Scientific Symposium will take place October 23-26 in San Francisco 

Annual Scientific Symposium will take place October 23-26 in San Francisco

September 6, 2023 — The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical trialsTCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. TCT, which will be held October 23-26, 2023 in San Francisco, California, at the Moscone Center, will be celebrating 35 years of leading the field. 

For more than three decades, TCT has ignited innovation, education, and connection in interventional cardiology, with the purpose of improving the survival and quality of life of patients suffering from heart and vascular disease. Every year, TCT features cutting-edge research in interventional cardiovascular medicine that directly impacts patient care and how physicians treat heart disease. 

In the fast-paced world of medical advancements, late-breaking trials are highly anticipated and offer clinicians the opportunity to learn about new interventions, drugs, techniques, or strategies that could potentially improve patient outcomes. The 12 studies selected for presentation at TCT examine the safety and effectiveness of minimally invasive techniques, pharmaceuticals, technologies, and devices that demonstrate potential to treat or prevent cardiovascular disease. Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Tuesday, October 24, Wednesday, October 25, and Thursday, October 26. 

PARTNER 3 Low-Risk 

Five-Year Clinical and Echocardiographic Outcomes from The PARTNER 3 Low-Risk Randomized Trial 

Martin B. Leon, MD 

EVOLUT Low Risk 

Four-Year Outcomes from the EVOLUT Low Risk Trial 

Michael J. Reardon, MD 


Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement — The WATCH TAVR Trial 

Samir R. Kapadia, MD 


Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement System in High-Risk Patients with Symptomatic Severe Native Aortic Regurgitation 

Vinod H. Thourani, MD 


Primary Outcomes of the Esprit BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions: The LIFE-BTK Randomized Controlled Trial 

Ramon L. Varcoe, MD 


Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon with Conventional Balloon Angioplasty for In-Stent Restenosis 

Robert W. Yeh, MD 


Less Than 1-month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy after Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: The T-PASS Randomized Trial 

Myeong-Ki Hong, MD 


Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The Randomized PICSO-AMI-I Trial 

Giovanni Luigi De Maria, MD 


A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients With Severe Tricuspid Regurgitation: The TRISCEND II Trial 

Susheel K. Kodali, MD 


Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results from the Randomized TRILUMINATE Pivotal Trial 

Suzanne V. Arnold, MD 


Transcatheter versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial) 

Josep Rodés-Cabau, MD 


One Year Outcomes from a Randomized Comparison of Transcatheter Edge-to-Edge Repair Systems For Degenerative MR: The CLASP IID Trial and Registry 

Robert L. Smith, MD and Firas Zahr, MD 

The Preliminary Program Guide can be found here: https://tct2023.crfconnect.com/program-guide. Media are invited to attend TCT and can apply for media credentials at: https://tct2023.crfconnect.com/press-registration

Find more TCT23 conference coverage here 

Related TCT Coverage: 

VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation 

VIDEO: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial 

VIDEO: Unique Features of Coronary Artery Disease in Women 

Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review 

Photo Gallery Highlighting TCT 2022 

Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review 

TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award 

TCT 2022 Announces Winner of Shark Tank Innovation Award 

Educational Leaders Join Forces on Educational Opportunities 

Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF) 

Related Content

News | TCT

June 26, 2023 — Building on the resounding success of last year’s standing-room-only debut, the Cardiovascular Research ...

Home June 26, 2023
Videos | TCT

At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional ...

Home November 03, 2022
Videos | TCT

At TCT 2022, Jane Leopold, MD, a cardiologist at Brigham and Women’s Hospital; Director, Women's Interventional ...

Home October 26, 2022
Feature | TCT | Christine Book

October 17, 2022 — Significant findings from the highly-anticipated EPIC-STEMI study were presented during a late ...

Home October 17, 2022
Videos | TCT

At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's ...

Home October 13, 2022
Feature | TCT | By Christine Book

The 34th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research ...

Home October 03, 2022
News | TCT

September 22, 2022 — The recipient of the TCT 2022 Thomas J. Linnemeier “Spirit of Interventional Cardiology” Young ...

Home September 22, 2022
News | TCT

September 19, 2022 — Puzzle Medical Devices, a provider of hemodynamic support in Heart Failure (HF), was selected as ...

Home September 20, 2022
News | TCT

September 16, 2022 — Edwards Lifesciences Corporation, today announced the company's PASCAL Precision transcatheter ...

Home September 16, 2022
Subscribe Now